Novo Nordisk cuts prices of Ozempic, Wegovy in India again to fend off generics competition
Novo Nordisk on Tuesday cut the prices of its diabetes and weight-loss drugs Ozempic and Wegovy by as much as 36% and 48% in India, its second such move, to fend off competition from local drugmakers’ cheaper generics. Ozempic’s and

